PEGINTERFERON BETA-1a (Plegridy®)

Clinical Indication

Relapsing-remitting multiple sclerosis

Comments

In line with NICE TA624

Date of classification

May 2020

Review date

May 2020

Red

Drugs which should be prescribed only by hospital specialists (clinical review by specialist as appropriate and annually as a minimum).